Nmible
- Company typePrivate
- Founded2020
- HeadquartersHarrow, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Nmible does
Nmible is a privately held, early-stage company headquartered in Harrow, United Kingdom, founded in 2020. Per its public firmographic profile, the company provides clinical trial participant reimbursement solutions to the life sciences industry — addressing the operational workflow of paying and reimbursing participants enrolled in clinical studies, a function typically performed by pharmaceutical sponsors and contract research organizations (CROs). The company is led by Jonathan Anderson, Founder and CEO.
The available source material offers no detail on Nmible's product architecture, underlying technology stack, integration footprint, proprietary features, or competitive differentiation. The firm's website (nmible.com) was observed to display only a loading/verification placeholder rather than substantive product content, and no patents, certifications, partnerships, awards, product launches, or technology disclosures were captured. Consequently, the technical and commercial mechanics of the offering cannot be characterized beyond the stated reimbursement-services value proposition.
On the commercial side, the company operates with a headcount in the 1–10 range and has no disclosed revenue, funding history, pricing model, customer base, or distribution channels in the supplied data. Ownership, subsidiary structure, and operating geographies beyond the Harrow, UK headquarters are likewise not documented. The combination of a niche regulated vertical (clinical trial finance) and minimal public footprint is consistent with either a very early commercial stage or a pre-commercial posture; the source material does not allow further differentiation between these readings.
Nmible firmographics
Firmographics- Name
- Nmible
- Website
- https://nmible.com
- Company type
- Private
- Founded year
- 2020
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Nmible industry classification
Industry- Product category
- Clinical Trial Participant Reimbursement Software
- NAICS
- Professional, Scientific, and Technical Services (541)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Financial Management & Payments (Site Budgeting) (HLAGACAM)
- akta.pro secondary industry
- Patient Access Programs & Affordability (Copay/Hubs/PSP) (HLAIAKAG)
Keywords
Where Nmible is headquartered
LocationHeadquarters
- HQ city
- Harrow
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
Nmible business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Nmible product offering
Product offeringCore offering
Nmible provides clinical trial participant reimbursement solutions to the life sciences industry. The company enables sponsors and contract research organizations to manage payments to trial participants, though specific product functionality is not detailed in available public sources.
Differentiator
Problem solved
Functional benefit
Companies that use Nmible
Customer profileIdeal customer profiles1 record
Nmible technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Nmible partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights1 record
Nmible competitors and assessment
Company assessmentBroad incumbents
- Oracle Health Sciences:
- Veeva Systems: Veeva provides clinical trial and site management software (Veeva Vault Clinical) widely used by sponsors and CROs, representing adjacent infrastructure that touches trial finance and site operations.
- Medidata Solutions: Medidata (Dassault Systèmes) offers the Medidata Clinical Cloud including financial and site management tools used by sponsors running clinical trials, overlapping with participant reimbursement workflows.
- IQVIA: IQVIA is a global CRO and clinical trial technology provider with site payment and financial management capabilities, making it a broad incumbent in the same customer workflow that Nmible serves.
Direct peers
- Greenphire: Greenphire is the dominant provider of clinical trial participant payment and reimbursement solutions (ClinCard) and is the most direct competitor to Nmible's stated offering.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat2 records
Key risks5 records
Key highlights4 records
Customer concentration
Nmible social profiles
Digital presenceNmible financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nmible leadership team
Management profileNumber of profiles
Profiles1 record
Nmible funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nmible M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nmible
What does Nmible do?
Nmible provides clinical trial participant reimbursement solutions to the life sciences industry. The company enables sponsors and contract research organizations to manage payments to trial participants, though specific product functionality is not detailed in available public sources.
When was Nmible founded?
Nmible was founded in 2020. It employs 1 to 10 people.
Where is Nmible based?
Nmible is headquartered in Harrow, United Kingdom, in the Europe region.
Who are Nmible's main competitors?
Broad incumbents on record are Oracle Health Sciences, Veeva Systems, Medidata Solutions and IQVIA. Greenphire is listed as a direct peer.
Does Nmible have an API?
No public API is recorded for Nmible.
What industry is Nmible in?
Nmible's product category is Clinical Trial Participant Reimbursement Software. Its primary akta.pro industry code is HLAGACAM, Clinical Trial Financial Management & Payments (Site Budgeting), with a secondary code of HLAIAKAG, Patient Access Programs & Affordability (Copay/Hubs/PSP). Its NAICS code is 541 and its SIC code is 8731.